scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0006-8993(01)02069-8 |
P698 | PubMed publication ID | 11259776 |
P50 | author | Seiji Ito | Q44583406 |
P2093 | author name string | H Mori | |
K Sakimura | |||
M Mishina | |||
T Minami | |||
E Okuda-Ashitaka | |||
S Matsumura | |||
K Shimamoto | |||
P2860 | cites work | Reduced hippocampal LTP and spatial learning in mice lacking NMDA receptor epsilon 1 subunit | Q24309045 |
Functional consequences of NR2 subunit composition in single recombinant N-methyl-D-aspartate receptors | Q24654640 | ||
Antinociceptive activity of CP-101,606, an NMDA receptor NR2B subunit antagonist | Q24672789 | ||
Differential expression of two glial glutamate transporters in the rat brain: quantitative and immunocytochemical observations | Q28236376 | ||
DL-threo-beta-benzyloxyaspartate, a potent blocker of excitatory amino acid transporters | Q28261635 | ||
Nociceptive effects induced by intrathecal administration of prostaglandin D2, E2, or F2 alpha to conscious mice | Q28334553 | ||
Impairment of suckling response, trigeminal neuronal pattern formation, and hippocampal LTD in NMDA receptor epsilon 2 subunit mutant mice | Q28507147 | ||
Reduced spontaneous activity of mice defective in the epsilon 4 subunit of the NMDA receptor channel | Q28585536 | ||
Glutamate transporter GLT-1 is transiently localized on growing axons of the mouse spinal cord before establishing astrocytic expression | Q28588863 | ||
Molecular diversity of glutamate receptors and implications for brain function | Q28611078 | ||
Ethical guidelines for investigations of experimental pain in conscious animals | Q29617510 | ||
Cloned glutamate receptors | Q29619950 | ||
Excitatory amino acid transporters: a family in flux | Q33636707 | ||
Inhibition of uptake unmasks rapid extracellular turnover of glutamate of nonvesicular origin. | Q35563396 | ||
The excitatory amino acid receptors: their classes, pharmacology, and distinct properties in the function of the central nervous system | Q38272501 | ||
Nitric oxide (NO) and nociceptive processing in the spinal cord | Q40887811 | ||
Structure and function of the NMDA receptor channel | Q40950619 | ||
Mechanical allodynia in rats is blocked by a Ca2+ permeable AMPA receptor antagonist | Q41711894 | ||
The effects of substance P analogues on the scratching, biting and licking response induced by intrathecal injection of N-methyl-d-aspartate in mice | Q41897432 | ||
Prostaglandins inhibit endogenous pain control mechanisms by blocking transmission at spinal noradrenergic synapses | Q42200367 | ||
Behavioral classification of excitatory amino acid receptors in mouse spinal cord | Q42202633 | ||
Cyclooxygenase inhibition and the spinal release of prostaglandin E2 and amino acids evoked by paw formalin injection: a microdialysis study in unanesthetized rats. | Q44603003 | ||
Antagonism at the glycine site on the NMDA receptor reduces spinal nociception in the rat | Q45364633 | ||
Hyperalgesia mediated by spinal glutamate or substance P receptor blocked by spinal cyclooxygenase inhibition | Q46223466 | ||
Prostanoid synthesis in the spinal cord enhances excitability of dorsal horn convergent neurones during reperfusion of ischaemic receptive fields on the rat's tail | Q46755768 | ||
Glutamate transporter protein subtypes are expressed differentially during rat CNS development. | Q48617168 | ||
CP-101,606, a potent neuroprotectant selective for forebrain neurons | Q48656217 | ||
Involvement of glutamate receptors in strychnine- and bicuculline-induced allodynia in conscious mice. | Q50749887 | ||
SYM-2081 a kainate receptor antagonist reduces allodynia and hyperalgesia in a freeze injury model of neuropathic pain. | Q51414552 | ||
Distinct spatiotemporal distributions of the N-methyl-D-aspartate receptor channel subunit mRNAs in the mouse cervical cord. | Q52215683 | ||
Selective NMDA NR2B antagonists induce antinociception without motor dysfunction: correlation with restricted localisation of NR2B subunit in dorsal horn. | Q52535137 | ||
Pharmacologically induced selective degeneration of chemosensitive primary sensory neurones | Q59082877 | ||
Involvement of primary afferent C-fibres in touch-evoked pain (allodynia) induced by prostaglandin E2 | Q60735264 | ||
Prostaglandin E2 stimulates glutamate release from synaptosomes of rat spinal cord | Q60735308 | ||
Involvement of glutamate receptors in allodynia induced by prostaglandins E2 and F2α injected into conscious mice | Q60735328 | ||
Allodynia evoked by intrathecal administration of prostaglandin F2α to conscious mice | Q60735339 | ||
Is substance P a primary afferent neurotransmitter for nociceptive input? I. Analysis of pain-related behaviors resulting from intrathecal administration of substance P and 6 excitatory compounds | Q69034249 | ||
Behavioral and autonomic correlates of the tactile evoked allodynia produced by spinal glycine inhibition: effects of modulatory receptor systems and excitatory amino acid antagonists | Q69349896 | ||
Intrathecal morphine in mice: a new technique | Q71852099 | ||
Allodynia evoked by intrathecal administration of prostaglandin E2 to conscious mice | Q72692259 | ||
Involvement of increased excitatory amino acids and intracellular Ca2+ concentration in the spinal dorsal horn in an animal model of neuropathic pain | Q73574695 | ||
The distribution of neurons expressing calcium-permeable AMPA receptors in the superficial laminae of the spinal cord dorsal horn | Q74582907 | ||
P433 | issue | 1-2 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 178-185 | |
P577 | publication date | 2001-03-01 | |
P1433 | published in | Brain Research | Q4955782 |
P1476 | title | Characterization of the glutamatergic system for induction and maintenance of allodynia | |
P478 | volume | 895 |
Q34809091 | Activation of presynaptic NMDA receptors coupled to NaV1.8-resistant sodium channel C-fibers causes retrograde mechanical nociceptor sensitization |
Q34548123 | Acute and late effects on induction of allodynia by acromelic acid, a mushroom poison related structurally to kainic acid |
Q37150552 | Advanced Genetic Testing Comes to the Pain Clinic to Make a Diagnosis of Paroxysmal Extreme Pain Disorder |
Q44396263 | Altered expression and uptake activity of spinal glutamate transporters after nerve injury contribute to the pathogenesis of neuropathic pain in rats. |
Q40735769 | Altered spinal arachidonic acid turnover after peripheral nerve injury regulates regional glutamate concentration and neuropathic pain behaviors in rats |
Q38365390 | Cellular prion protein protects from inflammatory and neuropathic pain |
Q34469703 | Central and peripheral roles of prostaglandins in pain and their interactions with novel neuropeptides nociceptin and nocistatin |
Q34659433 | Descending control of pain |
Q34674426 | Effect of inhibition of spinal cord glutamate transporters on inflammatory pain induced by formalin and complete Freund's adjuvant |
Q27681642 | From molecular phylogeny towards differentiating pharmacology for NMDA receptor subtypes |
Q36948083 | Functional identification of NR2 subunits contributing to NMDA receptors on substance P receptor-expressing dorsal horn neurons |
Q40075691 | Glutamate Transport System as a Novel Therapeutic Target in Chronic Pain: Molecular Mechanisms and Pharmacology |
Q24806575 | Glutamate transporter: an unexpected target for some antibiotics |
Q46145789 | Impairment of VGLUT2 but not VGLUT1 signaling reduces neuropathy-induced hypersensitivity |
Q42118122 | Inward currents induced by ischemia in rat spinal cord dorsal horn neurons |
Q37416455 | N-methyl-D-aspartate (NMDA) receptor NR2 subunit selectivity of a series of novel piperazine-2,3-dicarboxylate derivatives: preferential blockade of extrasynaptic NMDA receptors in the rat hippocampal CA3-CA1 synapse |
Q34280777 | NR2B containing NMDA receptor dependent windup of single spinal neurons. |
Q40017929 | Neuroprotective effects of an extract from the inflamed skin of rabbits inoculated with vaccinia virus on glutamate-induced neurotoxicity in cultured neuronal cell line |
Q45022915 | Pituitary adenylate cyclase-activating polypeptide is required for the development of spinal sensitization and induction of neuropathic pain. |
Q57024045 | Pro-inflammatory and vasoconstricting prostanoid PGF2α causes no headache in man |
Q24812394 | Role of spinal cord glutamate transporter during normal sensory transmission and pathological pain states |
Q34396776 | Serine racemase regulated by binding to stargazin and PSD-95: potential N-methyl-D-aspartate-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (NMDA-AMPA) glutamate neurotransmission cross-talk. |
Q24814089 | Spinal cord NR1 serine phosphorylation and NR2B subunit suppression following peripheral inflammation |
Q35046127 | Structure-activity analysis of a novel NR2C/NR2D-preferring NMDA receptor antagonist: 1-(phenanthrene-2-carbonyl) piperazine-2,3-dicarboxylic acid |
Q45164398 | Sumatriptan (5-HT1B/1D-agonist) causes a transient allodynia |
Q37268387 | Synaptically evoked glutamate transporter currents in Spinal Dorsal Horn Astrocytes |
Q36816562 | The biology of the glutamatergic system and potential role in migraine |
Q37238795 | Transcript expression of vesicular glutamate transporters in lumbar dorsal root ganglia and the spinal cord of mice - effects of peripheral axotomy or hindpaw inflammation |
Q33294244 | Transient allodynia pain models in mice for early assessment of analgesic activity |
Q44454428 | Unaltered pain-related behavior in mice lacking NMDA receptor GluRepsilon 1 subunit |
Q50441233 | Zerumbone-induced antinociception: involvement of the L-arginine-nitric oxide-cGMP -PKC-K+ ATP channel pathways |